|
Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops |
Pijlman, FTA; Rigter, SM; Hoek, J; Goldschmidt, HMJ; Niesink, RJM |
| Addiction Biology, Volume 10, Number 2, pp. 171-180(10) |
June 2005 |
| |
|
Trajectories of adolescent alcohol and cannabis use into young adulthood |
Patton, George et al. |
| Addiction, Volume 102, Number 4, pp. 607-615(9) |
April 2007 |
| |
|
10 Things Every Parent, Teenager & Teacher Should Know About Marijuana |
Family Council on Drug Awareness |
|
|
| |
|
A British Study of Cannabis (Circa 1910 AD) |
|
| Red Eye Express #5 |
|
| |
|
A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions |
Moir et al. |
| Chemical Research in Toxicology [Electronic publication ahead of print] |
7/12/07 |
| |
|
A critical review of the research literature concerning some biological and psychological effects of cannabis |
Dr. Peter L. Nelson |
| Cannabis and the law in Queensland: A discussion paper. |
1993 |
| |
|
A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology |
Eubanks et al. |
| Molecular Pharmaceutics ASAP Article 10.1021/mp060066m |
9/8/06 |
| |
|
A preliminary DTI study showing no brain structural change associated with adolescent cannabis use |
Delisi et al. |
| Harm Reduction Journal 2006, 3:17 (electronic publication ahead of print) |
9 May 2006 |
| |
|
A Report of the National Commission on Ganja to the Prime Minister of Jamaica |
Prof. Barry Chevannes, Chairman, et al |
| National Commission on Ganja, Jamaica |
Aug 7, 2001 |
| |
|
A Review of Drugs Policy and Proposals for the Future |
The Association of Chief Police Officers |
| ACPO Drugs Committee |
April 2002 |
| |
|
A Smoking Gun? The impact of cannabis smoking on respiratory health |
|
| The British Lung Foundation |
11/11/02 |
| |
|
Acute effects of smoked marijuana and oral d-9-thc on specific airway conductance in asthmatic subjects |
Tashkin, Shapiro, and Frank |
| American Review of Respiratory Disease, Volume 109, p. 420-428 |
1974 |
| |
|
Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study |
Coffey, Carlin, Lynskey, Li and Patton |
| The British Journal of Psychiatry 182: 330-336 |
2003 |
| |
|
Adverse effects of cannabis |
Wayne Hall, Nadia Solowij |
| The Lancet, vol. 352, no. 9140, pp 1611-1616 |
14/11/98 |
| |
|
After the War on Drugs - Options for Control |
Steve Rolles and Danny Kushlick |
| Transform Drug Policy Foundation |
12/10/04 |
| |
|
Altered Minds - Cannabis and various graphs and tables |
|
| Channel 4 Citizen's Commission on Drugs |
1998 |
| |
|
Alternative systems of cannabis control in New Zealand - A discussion paper |
|
| Drug Policy Forum Trust, Wellington |
July 1997 |
| |
|
Alternative systems of cannabis control in New Zealand - References |
|
| Drug Policy Forum Trust, Wellington |
July 1997 |
| |
|
An endocannabinoid mechanism for stress-induced analgesia |
Hohmann et al. |
| Nature vol 435 p1108-1112 |
23/06/05 |
| |
|
An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. |
Brady et al. |
| Multiple Sclerosis 10(4):425-33 |
August 2004 |
| |
|
Analgesic and anti-inflammatory activity of constituents of Cannabis Sativa L. |
E.A. Formukong, A.T. Evans, and F.J. Evans |
| Inflammation, Vol 12, No. 4 |
1988 |
| |
|
Annual report on the state of the drugs problem in the European Union and Norway 2004 |
|
| European Monitoring Centre for Drugs and Drugs Addiction (EMCDDA) |
25/11/04 |
| |
|
Answers to frequently asked questions about marijuana use |
|
| The Drug Education Project |
|
| |
|
Anti-Tumor Effects |
GW Pharmaceuticals |
|
|
| |
|
Antiemetic effect of Delta-9-Tetrahydrocannabinol in patients receiving Cancer Chemotherapy |
Sallan, Stephen E., Norman E. Zinberg, and Emil Frei. |
| New England Journal of Medicine Vol. 293(16) 795-797. |
1975 |
| |
|
Antineoplastic activity of cannabinoids |
Munson, Harris, Friedman, Dewey and Carchman |
| Journal of the National Cancer Institute v55 no. 3 |
September 1975 |
| |
|
Anxiety with Depression Research Review |
Edward Glick |
| Oregon Medical Marijuana Act Debilitating Medical Conditions Advisory Panel |
27/03/00 |
| |
|
Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic re |
Campbell et al. |
| British Medical Journal 323(7303):13-6 |
07/07/01 |
| |
|
Association of cannabis use with prodromal symptoms of psychosis in adolescence |
Jouko Miettunen et al. |
| The British Journal of Psychiatry (2008) 192, 470–471. |
2008 |
| |
|
Attributes of long-term heavy cannabis users: a case-control study |
Gruber, Pope, Hudson and Yurgelun-Todd |
| Psychological Medicine, 33, 1415–1422. |
2003 |
| |
|
Back To Chernobyl |
Lila Guterman |
| New Scientist |
10 April 1999 |
| |
|
BMA report calls for change in law and development of new cannabis-based medicines |
|
| British Medical Association |
18/11/97 |
| |
|
Body's 'cannabis' could hold blood pressure key |
|
| BBC Online |
Dec 29, 1998 |
| |
|
Brain chemicals mimic marijuana |
Johnathon S. Choi |
| Reuters |
Aug 1997 |
| |
|
Building Toward The Future With Hemp |
Conde & Seber |
| High Times |
July 1994 |
| |
|
Business: Hemp's good habits |
|
| The Economist |
Aug 1, 1998 |
| |
|
Can health campaigns make people ill? The iatrogenic potential of population-based cannabis prevention |
Harry R Sumnall, Mark A Bellis |
| Journal of Epidemiology and Community Health 2007;61:930-931 |
2007 |
| |
|
Cannabidiol and D9-tetrahydrocannabinol are neuroprotective antioxidants |
Hampson, Grimaldi, Axelrod and Wink |
| Proceedings of the National Academy of Sciences Vol. 95, pp. 8268–8273 |
July 1998 |
| |
|
Cannabidiol: The Wonder Drug of the 21st Century? |
|
|
|
| |
|
Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse |
J H Allen, G M de Moore, R Heddle and J C Twartz |
| Gut 2004;53:1566-1570 |
November 2004 |
| |
|
Cannabinoids and Brain Injury |
Mechoulam, Panikashvili, Shohami |
| TRENDS in Molecular Medicine Vol.8 No.2 |
February 2002 |
| |
|
Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients |
Volfe Z., Dvilansky A., Nathan I. |
| Int J Clin Pharm. Res V (4) 243-246 |
1985 |
| |
|
Cannabinoids control spasticity and tremor in a multiple sclerosis model |
David Baker, et al. |
| Nature |
20 Jan 2000 |
| |
|
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review |
Tramer et al. |
| British Medical Journal 2001;323:1–8 |
7/7/01 |
| |
|
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study) |
Zajicek et al. |
| Lancet 2003; 362: 1517–26 |
2003 |
| |
|
Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential |
Ashton et al. |
| Journal of Psychopharmacology, Vol. 19, No. 3, 293-300 |
2005 |
| |
|
Cannabinoids on the Brain |
Andrew J. Irving, Mark G. Rae, Angela A. Coutts |
| TheScientificWorldJOURNAL (2002) 2, 632-648 |
2002 |
| |
|
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects |
Jiang et al. |
| Journal of Clinical Investigation [Electronic publication ahead of print] |
13/10/05 |
| |
|
Cannabinoids: Potential Anticancer Agents |
Manuel Guzman |
| Nature Reviews |
1 Oct 2003 |
| |
|
Cannabis (the Wootton Report) |
Advisory Committee On Drug Dependence |
| The Home Office |
01/11/68 |
| |
|
Cannabis - An update 1999 - 2002 |
Professor DJ Nutt & Dr JR Nash |
| Psychopharmacology Unit, University of Bristol |
March 2002 |
| |
|
Cannabis - Government Response |
The House of Lords, Science and Technology Committee |
|
4 March 1999 |
| |
|
Cannabis - our position for a Canadian public policy |
Pierre Claude Nolin (Chair) |
| The Senate Special Committee on Illegal Drugs (Canada) |
September 2002 |
| |
|
Cannabis amotivational syndrome and personality trait absorption: A review and reconceptualization |
Peter L. Nelson, Ph.D. |
| Imagination, Cognition and Personality, 14(1), 43-58. |
1994-5 |
| |
|
Cannabis and driving |
University of Adelaide and Transport SA |
| Australian Press |
21 October 199 |
| |
|
Cannabis and harm reduction |
Wendy Swift, Jane Copeland, Simon Lenton |
| Drug and Alcohol Review (2000) 19, 101-112 |
2000 |
| |
|
Cannabis and Health |
Michael Farrell and Bruce Ritson |
| The British Journal of Psychiatry (2001) 178: 98 |
2001 |
| |
|
Cannabis and pregnancy |
Balle J, Olofsson MJ, Hilden J |
| Ugeskr Laeger 161(36):5024-8 |
06/09/99 |
| |
|
Cannabis and Psychiatric Pathology: An update |
Luis Dominguez |
| The Journal of Applied Research vol. 4 no. 1 |
2004 |
| |
|
Cannabis and road safety - an outline of the research studies to examine the effects of cannabis on driving |
Dr G. B. Chesher |
| National Drug and Alcohol Research Centre University of New South Wales |
|
| |
|
Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales |
Hickman et al. |
| Addiction 102 (4), 597–606 |
2007 |
| |
|
Cannabis and schizophrenia: results of a follow-up study |
Dieter Caspari |
| European Archives of Psychiatry and Clinical Neuroscience 249 :45–49 |
1999 |
| |
|
Cannabis and the brain |
Leslie Iversen |
| Brain vol 126 p1252-1270. |
2003 |
| |
|
Cannabis and Tobacco Smoke are not Equally Carcinogenic |
Robert J Melamede |
| Harm Reduction Journal 2005, 2:21 |
18/10 /05 |
| |
|
Cannabis and tobacco: responding to claims made by the British Lung Foundation and related news coverage |
|
| Action on Health and Smoking |
November 2002 |
| |
|
Cannabis antagonists: a new era of social psychopharmacology? |
Nutt, D. |
| Journal of Psychopharmacology 19(1):3-4. |
January 2005 |
| |
|
Cannabis effects and dependency concerns in long-term frequent users |
Andrew D. Hathaway, Ph.D. |
| Under peer review for the journal 'Addiction' |
2002 |
| |
|
Cannabis for migraine treatment: The once and future prescription? An historical and scientific review |
Russo E. |
| Pain 1998;76(1-2):3-8. |
1998 |
| |
|
Cannabis in Africa |
|
| Geopolitical Drugs Dispatch |
1998/99 |
| |
|
Cannabis in Asia |
|
| Geopolitical Drugs Dispatch |
1998/99 |
| |
|
Cannabis in Europe |
|
| Geopolitical Drugs Dispatch |
1998/99 |
| |
|
Cannabis in the Americas |
|
| Geopolitical Drugs Dispatch |
1998/99 |
| |
|
Cannabis intoxication and fatal road crashes in France: population based case-control study |
Bernard Laumon, Blandine Gadegbeku, Jean-Louis Martin, Marie-Berthe Biechel |
| British Medical Journal 2005; 331: 1371 |
10/12/2005 |
| |
|
Cannabis Policy, Implementation and Outcomes |
van het Loo, Hoorens, van 't Hof, Kahan |
| RAND Europe |
2003 |
| |
|
Cannabis report of the Swiss Federal Commission for Drug Issues (EKDF) |
|
| Swiss Federal Commission for Drug Issues |
May 1999 |
| |
|
Cannabis treatments in Obstetrics and Gynecology: A historical review |
Ethan Russo |
| Journal of Cannabis Therapeutics Vol. 2, No. 3/4, p5-35 |
2002 |
| |
|
Cannabis Use and Cognitive Decline in Persons under 65 Years of Age |
Constantine G. Lyketsos, Elizabeth Garrett, Kung-Yee Liang, and James C. An |
| American Journal of Epidemiology Vol. 149, No.9 pages 794-800 |
1 May 1999 |
| |
|
Cannabis Use and Dependence in a New Zealand Birth Cohort |
David Ferguson and John Horwood |
| New Zealand Medical Journal 113 (1109): 1506-1508 |
12/05/00 |
| |
|
Cannabis use and mental health in secondary school children: Findings from a Dutch survey |
Monshouwer et al. |
| The British Journal of Psychiatry (2006) 188: 148-153 |
February 2006 |
| |
|
Cannabis use and mental health in young people: cohort study |
G C Patton, C Coffey, J B Carlin, L Degenhardt, M Lynskey, W Hall |
| The British Medical Journal vol 325 p 1195 |
23/11/02 |
| |
|
Cannabis use and misuse prevalence among people with psychosis |
Bob Green, Ross Young and David Kavanagh |
| The British Journal of Psychiatry (2005) 187: 306-313 |
2005 |
| |
|
Cannabis use and psychosis: a longitudinal population-based study |
van Os J, Bak M, Hanssen M, Bijl RV, de Graaf R, Verdoux H |
| American Journal of Epidemiology 156(4):319-27 |
15/08/02 |
| |
|
Cannabis use and psychosis: a review of clinical and epidemiological evidence |
Wayne Hall and Louisa Degenhardt |
| Australian and New Zealand Journal of Psychiatry 34(1): 26-34 |
February 2000 |
| |
|
Cannabis use and pyschosis |
Wayne Hall |
| Problematic Alcohol & Drug Use & Mental Illness, Melbourne |
February 1998 |
| |
|
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review |
Moore et al. |
| Lancet 2007; 370: 319–28 |
28/07/07 |
| |
|
Cannabis use and the risk of later schizophrenia: a review |
Filip Smit, Linda Bolier & Pim Cuijpers |
| Addiction Vol. 99 Issue 4 Page 425 |
April 2004 |
| |
|
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study |
L Arseneault, M Cannon, R Poulton, R Murray, A Caspi, T Moffitt |
| The British Medical Journal vol 325 p 1212 |
23/11/02 |
| |
|
Cannabis use is associated with schizotypy and attentional disinhibition |
Patrick D. Skosnika, Lea Spatz-Glenna, Sohee Park |
| Schizophrenia Research 48 (2001) 83-92 |
2001 |
| |
|
Cannabis use predicts future psychotic symptoms, and vice versa |
Ferdinand et al. |
| Addiction 100(5):605-11. |
May 2005 |
| |
|
Cannabis use to enhance sportive and non-sportive performances among French sport students |
Lorente at al. |
| Addictive Behaviors 30(7):1382-91 |
August 2005 |
| |
|
Cannabis use, a stepping stone to other drugs? The case of Amsterdam |
Peter Cohen & Arjan Sas |
| CEDRO Centre for Drug Research, University of Amsterdam |
1997 |
| |
|
Cannabis Vaporizer Combines Efficient Delivery of THC with Effective Suppression of Pyrolytic Compounds |
Gieringer, St. Laurent, Goodrich |
| Journal of Cannabis Therapeutics, Vol. 4(1) |
2004 |
| |
|
Cannabis – Proposals for a Harm Reduction Strategy |
J. Ditchfield, S. Lucas Brewer |
|
Oct 04, revise |
| |
|
Cannabis, cannabinoids and reproduction |
Boram Park, John McPartland and Michelle Glass |
| Prostaglandins, Leukotrienes and Essential Fatty Acids 70 189–197 |
2004 |
| |
|
Cannabis, Cognition, and Residual Confounding |
Harrison G. Pope, Jr, MD |
| Journal of the American Medical Association 2002;287 no. 9 |
06/03/02 |
| |
|
Cannabis, social control and exclusion: the importance of social ties |
Amnon J. Suissa |
| International Journal of Drug Policy Vol 12, 5-6, pp 385-396 |
01/11/01 |
| |
|
Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases |
Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jorgensen P. |
| British Journal of Psychiatry 2005 Dec;187:510-5. |
December 2005 |
| |
|
Cannabis: Medical reality versus authoritarian brutality |
Ian Williams Goddard |
|
1996 |
| |
|
Cannabis: The Scientific And Medical Evidence |
The House of Lords, Science and Technology Committee |
|
4 Nov 1998 |
| |
|
Causal association between cannabis and psychosis - examination of the evidence |
Arseneault, Cannon, Witton and Murray |
| British Journal of Psychiatry.184(2):110-117. |
February 2004 |
| |
|
Cerebellar Infarction in Adolescent Males Associated With Acute Marijuana Use |
Geller T, Loftis L, Brink DS. |
| Pediatrics (2004) 113;4:365-370 |
04/04/04 |
| |
|
Cerebrovascular perfusion in marijuana users during a month of monitored abstinence |
Herning et al. |
| Neurology 2005;64:488-493 |
2005 |
| |
|
Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation |
Schmid, Paria, Krebsbach, Schmid, Dey |
| Proceedings of the National Academy of Sciences 94(8):4188-92. |
15/04/97 |
| |
|
Changes in maternal marital status are associated with young adults' cannabis use: evidence from a 21-year follow-up of a birth cohort |
Hayatbakhsh et al. |
| International Journal of Epidemiology Advance Access |
05/04/06 |
| |
|
Cigarettes, Alcohol and Marijuana: Varying Associations with Birthweight |
Jennie Kline, Zena Stein and Michelle Hutzler |
| International Association of Epidemiology, Vol. 16, No. 1 |
1987 |
| |
|
Clinical Studies and Case Reports |
|
| International Association for Cannabis as Medicine |
|
| |
|
Cognitive functioning of long-term heavy cannabis users seeking treatment (and responses) |
Nadia Solowij et al. |
| Journal of the American Medical Association 2002;287:1123-1131 |
06/03/02 |
| |
|
Comparing cannabis with tobacco (and responses) |
Henry, Oldfield and Kon |
| British Medical Journal 326:942-943 |
03/05/2003 |
| |
|
Comparing cannabis with tobacco - again |
Stephen Sidney |
| British Medical Journal 2003;327:635-636 |
20/09/03 |
| |
|
Compounds found in Cannabis Sativa |
Schultes and Hofmann |
| The Botany and Chemistry of Hallucinogens |
|
| |
|
Conference on Cannabis Sativa L. |
|
|
14/01/37 |
| |
|
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth |
Maurizio Bifulco et al. |
| Federation of American Societies for Experimental Biology Journal |
29/10/01 |
| |
|
Counterblast to the I.O.M. |
Peter Webster |
| International Journal of Drug Policy |
1999 |
| |
|
Crew 2000 Annual Shop Survey 2005 |
|
| Crew 2000 |
29/03/06 |
| |
|
Crime and the Drug War |
Kirby R. Cundiff |
| Claustrophobia |
August 1994 |
| |
|
Criminal Policy Resarch Unit at the ACPO Drugs Conference |
Tiggy May |
| Association of Chief Police Officers drugs conference 2002, Blackpool |
05/09/02 |
| |
|
Dangerous Habits |
|
| The Lancet, vol. 352 no. 9140, pp1565 |
14/11/98 |
| |
|
Decreased depression in marijuana users |
Denson and Earleywine |
| Addictive Behaviors (electronic publication ahead of print) |
17/06/05 |
| |
|
Decreased respiratory symptoms in cannabis users who vaporize |
Mitch Earleywine and Sara Smucker Barnwell |
| Harm Reduction Journal 2007, 4:11 |
16/04/07 |
| |
|
Decriminalisation in Europe? Recent developments in legal approaches to drug use |
|
| European Monitoring Centre for Drugs and Drugs Addiction (EMCDDA) |
November 2001 |
| |
|
Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro |
Medveczky, Sherwood, Klein, Friedman, and Medveczky |
| BMC Medicine 2004, 2:34 |
15/09/04 |
| |
|
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction |
D'Souza et al. |
| Biological Psychiatry 15;57(6):594-608 |
March 2005 |
| |
|
Delta-9-Tetrahydrocannibinol as an antiemetic in cancer patients receiving high-dose Methotrexate |
Chang et al. |
| Annals of Internal Medicine 91: 819-824 |
December 1979 |
| |
|
Development of a rational scale to assess the harm of drugs of potential misuse |
Prof David Nutt, Leslie A King, William Saulsbury and Prof Colin Blakemore |
| The Lancet 2007; 369:1047-1053 |
2007 |
| |
|
Differential cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation |
Wang, Matsumoto, Guo, Paria, Roberts, Dey |
| Proceedings of the National Academy of Sciences vol 100, no 25, 14914-14919 |
9/12/03 |
| |
|
